BRAF is a Ras-activated serine/threonine protein kinase that participates in the MAP kinase/ERK signaling pathway (40), mutated in approximately 50% of melanomas [Catalogue of Somatic Mutations in Cancer (COSMIC) at http://www.sanger.ac.uk/cosmic] (41). The gene discussed is BRAF; the disease is melanoma.